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Previous published evidences showed that taking HAART once-daily (OD) is associated to better adherence when compared to
BID or TID regimens. However, no further studies investigated whether, among OD regimens, adherence levels can be differently
influenced. Aim of the study was to evaluate levels of self-reported adherence in HIV people according to type of HAART
dosing (STR, OD with more than one pill or BID). To limit reporting biases, the study was performed in five different non-clinic
settings covering North and Central Italy. A total of 230 patients on stable HAART were asked to complete a semi-structured,
anonymous questionnaire reporting their attitude toward HAART, their adherence and the acceptability of their regimen. Self-
perception of adherence was also investigated with a single item for comparison with real adherence behavior. Most of the
subjects were males (66%) with a mean age of 46 years, with higher education level (72%) and a long history of HIV infection
(mean 13.6 years). 17% of patients were on a first-line regimen. 21% reported to miss at least one dose during the past week
(STR: 6%; OD  1 pill 23% and BID 21%; pB0.05). People taking STR and BID tend to report less discontinuations (all the drug of
the day for at least 3 times in a month) compared to OD 1 pill (6 and 4% vs 11%). People taking therapies other than HAART
reported similar adherence levels of people taking only HAART, even when stratified for dosing groups. Even people judging their
adherence as ‘optimal’ or ‘very good’, 10 and 17% respectively, reported having missed a dose during the last week. At stepwise
regression model, optimal adherence was correlated to being male (OR: 2.38; 95% CI: 1.194.74), younger (OR: 3.04; 95% CI:
1.019.13) and with a shorter HIV infection (OR: 3.58; 95% CI: 1.0412.38). People taking simpler once-daily STR tend to report
better adherence than people taking OD 1 pill or BID. Perception of optimal adherence is largely variable among HIV-infected
people taking HAART, although only a minority of subjects showing less than perfect adherence do judge their behavior as
‘optimal’.
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